Acrivon Historical Balance Sheet

ACRV Stock

7.52 0.17 2.31%

Trend analysis of Acrivon Therapeutics, Common balance sheet accounts such as Short Long Term Debt Total of 4.2 M, Other Current Liabilities of 3.4 M or Total Current Liabilities of 14 M provides information on Acrivon Therapeutics,'s total assets, liabilities, and equity, which is the actual value of Acrivon Therapeutics, to its prevalent stockholders. By breaking down trends over time using Acrivon Therapeutics, balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Acrivon Therapeutics, latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Acrivon Therapeutics, is a good buy for the upcoming year.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acrivon Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

About Acrivon Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Acrivon Therapeutics, at a specified time, usually calculated after every quarter, six months, or one year. Acrivon Therapeutics, Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Acrivon Therapeutics, and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Acrivon currently owns. An asset can also be divided into two categories, current and non-current.

Acrivon Therapeutics, Balance Sheet Chart

At this time, Acrivon Therapeutics,'s Total Current Liabilities is fairly stable compared to the past year. Net Tangible Assets is likely to climb to about 205.8 M in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 4.2 M in 2024.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Total Stockholder Equity Common Stock Shares Outstanding

Add Fundamental

Total Assets

Total assets refers to the total amount of Acrivon Therapeutics, assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Acrivon Therapeutics, books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Acrivon Therapeutics, balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Acrivon Therapeutics, Common are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Most accounts from Acrivon Therapeutics,'s balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Acrivon Therapeutics, current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acrivon Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	5.6M	5.0M	4.6M	4.2M
Total Assets	106.6M	181.2M	138.3M	117.8M

Short Long Term Debt Total Total Assets

Acrivon Therapeutics, balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital
Total Assets		0.96	0.88	0.82	0.87	0.84	0.98	-0.68	-0.81	0.69	0.72	0.78	0.59	-0.62	0.99	0.72	0.22	0.94	0.89	0.39	0.87	0.97	-0.53	0.99	0.9	0.99
Short Long Term Debt Total	0.96		0.79	0.77	0.7	0.72	0.98	-0.86	-0.77	0.69	0.89	0.63	0.42	-0.6	0.98	0.65	0.47	0.81	0.75	0.63	0.7	0.97	-0.52	0.98	0.77	0.98
Other Current Liab	0.88	0.79		0.91	0.9	0.93	0.9	-0.42	-0.93	0.84	0.47	0.58	0.37	-0.81	0.89	0.74	-0.09	0.84	0.97	0.09	0.9	0.92	-0.64	0.89	0.97	0.88
Total Current Liabilities	0.82	0.77	0.91		0.77	0.95	0.86	-0.45	-1.0	0.98	0.53	0.41	0.17	-0.95	0.85	0.93	-0.08	0.73	0.85	0.16	0.77	0.87	-0.89	0.85	0.86	0.83
Total Stockholder Equity	0.87	0.7	0.9	0.77		0.92	0.8	-0.23	-0.78	0.63	0.29	0.84	0.71	-0.59	0.82	0.71	-0.27	0.96	0.98	-0.11	1.0	0.82	-0.48	0.82	0.98	0.81
Net Tangible Assets	0.84	0.72	0.93	0.95	0.92		0.83	-0.3	-0.95	0.87	0.37	0.62	0.42	-0.85	0.83	0.92	-0.26	0.87	0.94	-0.04	0.92	0.85	-0.79	0.83	0.95	0.82
Property Plant And Equipment Net	0.98	0.98	0.9	0.86	0.8	0.83		-0.74	-0.86	0.77	0.78	0.65	0.43	-0.71	1.0	0.72	0.29	0.86	0.87	0.47	0.8	1.0	-0.59	1.0	0.88	0.99
Net Debt	-0.68	-0.86	-0.42	-0.45	-0.23	-0.3	-0.74		0.44	-0.43	-0.99	-0.28	-0.1	0.34	-0.74	-0.32	-0.85	-0.41	-0.32	-0.94	-0.23	-0.72	0.29	-0.74	-0.34	-0.75
Retained Earnings	-0.81	-0.77	-0.93	-1.0	-0.78	-0.95	-0.86	0.44		-0.97	-0.51	-0.41	-0.17	0.95	-0.84	-0.91	0.09	-0.74	-0.87	-0.14	-0.78	-0.88	0.88	-0.85	-0.88	-0.83
Accounts Payable	0.69	0.69	0.84	0.98	0.63	0.87	0.77	-0.43	-0.97		0.5	0.2	-0.05	-0.99	0.75	0.9	-0.06	0.57	0.74	0.18	0.63	0.79	-0.94	0.75	0.75	0.73
Cash	0.72	0.89	0.47	0.53	0.29	0.37	0.78	-0.99	-0.51	0.5		0.31	0.12	-0.41	0.78	0.41	0.8	0.46	0.37	0.91	0.29	0.76	-0.38	0.78	0.4	0.79
Non Current Assets Total	0.78	0.63	0.58	0.41	0.84	0.62	0.65	-0.28	-0.41	0.2	0.31		0.96	-0.12	0.69	0.42	-0.04	0.92	0.74	0.03	0.84	0.64	-0.08	0.68	0.74	0.71
Non Currrent Assets Other	0.59	0.42	0.37	0.17	0.71	0.42	0.43	-0.1	-0.17	-0.05	0.12	0.96		0.12	0.48	0.22	-0.11	0.79	0.57	-0.09	0.71	0.42	0.15	0.47	0.57	0.5
Other Assets	-0.62	-0.6	-0.81	-0.95	-0.59	-0.85	-0.71	0.34	0.95	-0.99	-0.41	-0.12	0.12		-0.67	-0.87	0.14	-0.5	-0.71	-0.09	-0.59	-0.73	0.94	-0.68	-0.71	-0.65
Cash And Short Term Investments	0.99	0.98	0.89	0.85	0.82	0.83	1.0	-0.74	-0.84	0.75	0.78	0.69	0.48	-0.67		0.72	0.29	0.88	0.87	0.46	0.82	1.0	-0.57	1.0	0.88	1.0
Common Stock Shares Outstanding	0.72	0.65	0.74	0.93	0.71	0.92	0.72	-0.32	-0.91	0.9	0.41	0.42	0.22	-0.87	0.72		-0.19	0.7	0.74	0.06	0.71	0.73	-0.93	0.72	0.75	0.71
Non Current Liabilities Total	0.22	0.47	-0.09	-0.08	-0.27	-0.26	0.29	-0.85	0.09	-0.06	0.8	-0.04	-0.11	0.14	0.29	-0.19		-0.06	-0.2	0.97	-0.27	0.26	0.16	0.29	-0.17	0.3
Other Current Assets	0.94	0.81	0.84	0.73	0.96	0.87	0.86	-0.41	-0.74	0.57	0.46	0.92	0.79	-0.5	0.88	0.7	-0.06		0.93	0.09	0.96	0.86	-0.43	0.88	0.93	0.89
Other Stockholder Equity	0.89	0.75	0.97	0.85	0.98	0.94	0.87	-0.32	-0.87	0.74	0.37	0.74	0.57	-0.71	0.87	0.74	-0.2	0.93		-0.03	0.98	0.88	-0.56	0.87	1.0	0.86
Total Liab	0.39	0.63	0.09	0.16	-0.11	-0.04	0.47	-0.94	-0.14	0.18	0.91	0.03	-0.09	-0.09	0.46	0.06	0.97	0.09	-0.03		-0.11	0.43	-0.09	0.46	0.0	0.47
Net Invested Capital	0.87	0.7	0.9	0.77	1.0	0.92	0.8	-0.23	-0.78	0.63	0.29	0.84	0.71	-0.59	0.82	0.71	-0.27	0.96	0.98	-0.11		0.82	-0.48	0.82	0.98	0.81
Property Plant And Equipment Gross	0.97	0.97	0.92	0.87	0.82	0.85	1.0	-0.72	-0.88	0.79	0.76	0.64	0.42	-0.73	1.0	0.73	0.26	0.86	0.88	0.43	0.82		-0.6	1.0	0.9	0.99
Short Long Term Debt	-0.53	-0.52	-0.64	-0.89	-0.48	-0.79	-0.59	0.29	0.88	-0.94	-0.38	-0.08	0.15	0.94	-0.57	-0.93	0.16	-0.43	-0.56	-0.09	-0.48	-0.6		-0.57	-0.57	-0.55
Total Current Assets	0.99	0.98	0.89	0.85	0.82	0.83	1.0	-0.74	-0.85	0.75	0.78	0.68	0.47	-0.68	1.0	0.72	0.29	0.88	0.87	0.46	0.82	1.0	-0.57		0.88	1.0
Capital Stock	0.9	0.77	0.97	0.86	0.98	0.95	0.88	-0.34	-0.88	0.75	0.4	0.74	0.57	-0.71	0.88	0.75	-0.17	0.93	1.0	0.0	0.98	0.9	-0.57	0.88		0.87
Net Working Capital	0.99	0.98	0.88	0.83	0.81	0.82	0.99	-0.75	-0.83	0.73	0.79	0.71	0.5	-0.65	1.0	0.71	0.3	0.89	0.86	0.47	0.81	0.99	-0.55	1.0	0.87

Click cells to compare fundamentals

Acrivon Therapeutics, Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Acrivon Stock Analysis

When running Acrivon Therapeutics,'s price analysis, check to measure Acrivon Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acrivon Therapeutics, is operating at the current time. Most of Acrivon Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Acrivon Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acrivon Therapeutics,'s price. Additionally, you may evaluate how the addition of Acrivon Therapeutics, to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Acrivon Historical Balance Sheet

About Acrivon Balance Sheet Analysis

Acrivon Therapeutics, Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Common Stock Shares Outstanding

Acrivon Therapeutics, balance sheet Correlations

Acrivon Therapeutics, Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Acrivon Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Invested Capital	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Cash And Short Term Investments
Total Current Assets	+ 1.0	Cash And Short Term Investments

Retained Earnings	- 1.0	Total Current Liabilities
Other Assets	- 0.99	Accounts Payable
Cash	- 0.99	Net Debt
Accounts Payable	- 0.97	Retained Earnings
Retained Earnings	- 0.95	Net Tangible Assets
Other Assets	- 0.95	Total Current Liabilities